Abstract:Background: Estradiol, as an important hormone in follicular development and endometrial receptivity, is closely related to clinical outcomes of fresh in vitro fertilization embryo transfer (IVF-ET) cycles. The aim of this retrospective study was to evaluate the association between elevated serum estradiol (E-2) levels on the day of human chorionic gonadotrophin (hCG) administration and IVF-ET pregnancy and birth outcomes. Methods: A total of 1771 infertile patients with their first fresh IVF-ET cycles were analyzed retrospectively between January 2011 and January 2016 in Peking University First Hospital. Patients were categorized by serum E2 levels on the day of hCG administration into six groups: group 1 (serum E-2 levels < 1000 pg/mL, n = 205), group 2 (serum E-2 levels 1001-2000 pg/mL, n = 457), group 3 (serum E-2 levels 2001-3000 pg/mL, n = 425), group 4 (serum E-2 levels 3001-4000 pg/mL, n = 310), group 5 (serum E2 levels 40015000 pg/mL, n = 237), and group 6 (serum E-2 levels > 5000 pg/mL, n = 137). The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates of the groups were compared as the first objective of the study. For the 360 women with singleton births among all patients, the area under the corresponding receiver operating characteristic curve (ROC curve) was calculated to assess the predictive value of the E-2 change for the probability of low birth weight (LBW) infants as the second objective. Results: The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates gradually increased from groups 1 to 5 but decreased in group 6. The parameters of group 1 were statistically worse than those of the other groups, from group 2 to group 6 (the number of retrieved oocytes, t = 13.096, t = 23.307, t = 23.086, t = 26.376, t = 19.636, P < 0.003; the number of retrieved MII oocytes, t = 10.856, t = 20.868, t = 21.874, t = 23.374, t = 19.092, P < 0.003; the implantation rate, chi(2) = 12.179, chi(2) = 22.239, chi(2) = 23.993, chi(2) = 23.344, chi(2) = 16.758, P < 0.003; the clinical pregnancy rate, chi(2) = 16.415, chi(2) = 28.074, chi(2) = 35.387, chi(2) = 37.025, chi(2) = 24.590, P < 0.003). ROC analysis revealed that when a serum peak E-2 of 3148 pg/mL was used to predict LBW. Conclusions: The results indicate that serum E-2 levels have a concentration-dependent effect on clinical outcomes. The optimal range of the E-2 level during a fresh IVF-ET cycle is 1000 to 3148 pg/mL.

Increased Maternal Serum Hcg Concentrations in the Presence of a Female Fetus As Early As 2 Weeks after IVF-ET.

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

Serum LH Levels on hCG Trigger Day Affect IVF Outcomes Intensified by Poor Ovarian Reserve and Advanced Age

Recurrent Ivf Failure Is Associated With Elevated Progesterone On The Day Of Hcg Administration

Positive Association of the Number of Oocyte Retrieved with the Maternal Hcg Concentration in Early Pregnancy Achieved by Vitrified-Warmed Embryo Transfer after in Vitro Maturation

The Value of HCG Serum Concentrations after Trigger in Predicting Pregnancy and Live Birth Rates in IVF–ICSI

Positive Association of the Number of Oocyte Retrievals with the Maternal Hcg Concentration in Early Pregnancy after in Vitro Maturation

Double Measurements of Serum HCG Concentration and Its Ratio May Predict IVF Outcome.

Association Between Serum Estradiol Level on the Human Chorionic Gonadotrophin Administration Day and Clinical Outcome.

Combined analysis of human chorionic gonadotrophin concentrations at different time points after frozen-thawed blastocyst transfer can improve our ability to predict the pregnancy outcomes of single gestations

High Maternal Serum Estradiol in First Trimester of Multiple Pregnancy Contributes to Small for Gestational Age via DNMT1-Mediated CDKN1C Upregulation

Levels of serum β-human chorionic gonadotropin after embryo transfer and subsequent miscarriage, pre-eclampsia, and intrauterine growth restriction

Paired Detection of Serum Human Chorionic Gonadotropin Possibly Predicting Pregnant Outcome after in Vitro Fertilization-a Large Scale Retrospective Research

Early Rise of Serum hCG in Gestational Diabetes Mellitus Women With Live Birth Through In Vitro Fertilization Procedure

Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort

Predictive Value of Early Serum Beta-Human Chorionic Gonadotropin Measurements After Cleavage or Blastocyst Embryo Transfers

Human Chorionic Gonadotropin, Fetal Sex and Risk of Hypertensive Disorders of Pregnancy: A Nested Case-Control Study

Effects of Different Fertilizations Upon Serum HCG Level of IVF Versus ET in Early Pregnancy

Serum Human Chorionic Gonadotropin Among Women With and Without Obesity After Single Embryo Transfers

Evolution of serum progesterone levels in the very early luteal phase of stimulated IVF/ICSI cycles post hCG trigger: a proof of concept study

High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth.